FibroBiologics Inc. Common Stock

FBLG | NASDAQ

$1.36

$0 (0.00%)

Sep 22, 2026, 1:17 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-18.65M	-11.16M	-16.49M	-5.12M	-1.58M	-1.17M
Depreciation & Amortization	832K	573K	437K	94K	n/a	n/a
Stock-Based Compensation	2.69M	2.22M	1.77M	265K	n/a	n/a
Other Working Capital	-3.31M	-694K	-178K	-218K	172K	n/a
Other Non-Cash Items	2.05M	-4.09M	7.39M	389K	233K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.31M	559K	493K	307K	172K	n/a
Operating Cash Flow	-16.39M	-11.9M	-6.4M	-4.07M	-1.41M	-1.17M
Capital Expenditures	-262K	-184K	-495K	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-262K	-184K	-495K	n/a	n/a	n/a
Debt Repayment	975K	9.4M	300K	3.78M	1.53M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-2.65M	n/a	292K	1.17M
Financial Cash Flow	7.57M	16.91M	13.79M	5.93M	1.82M	1.17M
Net Cash Flow	-9.09M	4.82M	6.9M	1.86M	407K	n/a
Free Cash Flow	-16.66M	-12.09M	-6.9M	-4.07M	-1.41M	-1.17M
Adj. Free Cash Flow	-19.34M	-14.3M	-8.66M	-4.33M	-1.41M	-1.17M
Maintenance CapEx	-262K	-184K	-437K	n/a	n/a	n/a
Growth CapEx	n/a	n/a	-58K	n/a	n/a	n/a
Owner Earnings	-16.66M	-12.09M	-6.84M	-4.07M	-1.41M	-1.17M